Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung cancer incidence and mortality in China: Updated statistics and an overview of temporal trends from 2000 to 2016
Rongshou Zheng, Siwei Zhang, Shaoming Wang, et al.
Journal of the National Cancer Center (2022) Vol. 2, Iss. 3, pp. 139-147
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Long-term trends of lung cancer incidence and survival in southeastern China, 2011–2020: a population-based study
Yan Zhou, Zhisheng Xiang, Weikai Lin, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Natural Compounds for Preventing Age-Related Diseases and Cancers
Mi‐Ran Ki, Sol Youn, Dong Hyun Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7530-7530
Open Access | Times Cited: 7
Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study)
Yu Wang, Lei Deng, Jianyang Wang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5
Telemedicine-Enhanced Lung Cancer Screening Using Mobile Computed Tomography Unit with Remote Artificial Intelligence Assistance in Underserved Communities: Initial Results of a Population Cohort Study in Western China
Wenjuan Tao, Xiru Yu, Jun Shao, et al.
Telemedicine Journal and e-Health (2024) Vol. 30, Iss. 6, pp. e1695-e1704
Closed Access | Times Cited: 4
Soluble starch nanoparticles loaded with Gefitinib for treating lung cancer: Optimization and cytotoxicity assessment
Mohammed A. Amin, Hamdoon A. Mohammed
International Journal of Biological Macromolecules (2025), pp. 140369-140369
Closed Access
The critical role of immune response in lung cancer and its treatment progress
Ying Zhang
New discovery. (2025), pp. 1-12
Closed Access
Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Single‐Arm Study
Xiaoyi Feng, Xiaoping Xiao, Hui Guan, et al.
Thoracic Cancer (2025) Vol. 16, Iss. 6
Open Access
“I Saw it Incidentally but Frequently”: Exploring the Effects of Online Health Information Scanning on Lung Cancer Screening Behaviors Among Chinese Smokers
Luxi Zhang, Jizhou Francis Ye, Xinshu Zhao
Health Communication (2024), pp. 1-12
Closed Access | Times Cited: 3
Diagnostic Potential of Serum Glycome Analysis in Lung Cancer: A Glycopattern Study
Wenhua Hu, Wei Ge, Peng Xia, et al.
Journal of Proteome Research (2023) Vol. 23, Iss. 1, pp. 500-509
Closed Access | Times Cited: 7
Risk-adapted starting age of personalized lung cancer screening: a population-based, prospective cohort study in China
Chenran Wang, Xuesi Dong, Fengwei Tan, et al.
CHEST Journal (2024) Vol. 165, Iss. 6, pp. 1538-1554
Closed Access | Times Cited: 2
Identification of cellular senescence-associated genes as new biomarkers for predicting the prognosis and immunotherapy response of non-small cell lung cancer and construction of a prognostic model
Dandan Xu, Xiaohong Chen, Mingyuan Wu, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28278-e28278
Open Access | Times Cited: 2
Hydrogel based Flexible wearable sweat sensor for SERS-AI monitoring treatment effect of Lung Cancer
Zhaoxian Chen, Shihong Liu, Wenrou Yu, et al.
Sensors and Actuators B Chemical (2024), pp. 137155-137155
Closed Access | Times Cited: 2
Profile of patients with lung cancer at a tertiary care hospital in Nepal: A retrospective analysis
Birendra Kumar Yadav, Alok Thakur, Akash Pradhan, et al.
Cancer Research Statistics and Treatment (2024) Vol. 7, Iss. 4, pp. 396-402
Open Access | Times Cited: 2
Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy
Yu Wang, Wenqing Wang, Tao Zhang, et al.
Journal of the National Cancer Center (2024) Vol. 4, Iss. 2, pp. 177-187
Open Access | Times Cited: 1
Network pharmacology integrated with experimental validation revealed potential molecular mechanisms of Camellia nitidissima C. W. Chi in the treatment of lung cancer
Ailing Zhou, Chong Zhou, Duanheng Wang, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116576-116576
Closed Access | Times Cited: 3
Updated Efficacy and Safety of Lorlatinib in a Phase 2 Study in Chinese Patients With Previously Treated Advanced ALK‐Positive Non‐small Cell Lung Cancer
Shun Lü, Qing Zhou, Xiaoqing Liu, et al.
Clinical Lung Cancer (2024) Vol. 25, Iss. 7, pp. e295-e303.e4
Open Access
Lung cancer surgery: innovations and future perspectives
Xiangyang Yu, Feng Wang, Kai Ma, et al.
Clinical Cancer Bulletin (2024) Vol. 3, Iss. 1
Open Access
Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition
Tingting Du, Xiaowen Hu, Zhenyan Hou, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access
Distant metastatic patterns in young and old non-small cell lung cancer patients: a dose‒response analysis based on SEER population
Yingxian Dong, Sicheng Zhou, Jue Li, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36657-e36657
Open Access
Artificial intelligence-assisted delineation for postoperative radiotherapy in patients with lung cancer: a prospective, multi-center, cohort study
Han Zi-ming, Yu Wang, Wenqing Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Global, regional, and national lifetime risk of developing and dying from lung cancer in 2022: A population-based study in 185 countries
Meng Li, Xin Wen, Xin Liang, et al.
Chinese Medical Journal (2024)
Open Access
Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024
Qinling Jiang, Zhiqiang Wei, Pingping Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The survival benefit from surgery on patients with large-cell neuroendocrine carcinoma in the lung: a propensity-score matching study
Hao Jiang, Weixia Xie, Xianpeng Li, et al.
Journal of Cardiothoracic Surgery (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Geographical and sexual disparities of lung cancer mortality trends in China: A population-based study
Wenkai Huang, Zhai Guang-hong, Hang Dong, et al.
The Innovation Medicine (2023) Vol. 1, Iss. 3, pp. 100032-100032
Open Access | Times Cited: 1
Geographical and Sexual Disparities of Lung Cancer Mortality Trends in China: A Population-Based Study
Wenkai Huang, Zhai Guang-hong, Hang Dong, et al.
(2023)
Closed Access
Page 1 - Next Page

Scroll to top